Results 1 to 10 of about 112,487 (306)

U.S. Medicaid managed care markets: explaining state policy choice variation [PDF]

Insurance Markets and Companies, 2012
David Randall, Stephen T. Parente
doaj  

Portfolio Insurance a comparison of naive versus standard strategies [PDF]

Insurance Markets and Companies, 2014
Jorge Costa, Raquel M. Gaspar
doaj  

Competition between health maintenance organizations and nonintegrated health insurance companies in health insurance markets. [PDF]

Health Econ Rev, 2015
Baranes E, Bardey D.
europepmc   +1 more source

Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patients. [PDF]

Neurol Clin Pract, 2016
Bourdette DN, Hartung DM, Whitham RH.
europepmc   +1 more source

Can chronic pain kill? [PDF]

Orthop Rev (Pavia)
Abd-Elsayed A, Hasoon J, Deer T.
europepmc   +1 more source

Cervical Cancer Screening Program by Visual Inspection: Acceptability and Feasibility in Health Insurance Companies. [PDF]

Obstet Gynecol Int, 2015
Horo AG, Didi-Kouko Coulibaly J, Koffi A, Tchounga B, Seni K, Aka KE, Kone M.   +6 more
europepmc   +1 more source

Lumbar stenosis surgery: Spine surgeons not insurance companies should decide when enough is better than too much.

Surg Neurol Int, 2017
Epstein NE.
europepmc   +1 more source

Assessing the impact of pharmacist-led interventions on glucagon-like peptide 1 receptor agonist access and treatment outcomes. [PDF]

J Manag Care Spec Pharm
Huddleston H, Martinez J, Cook J, Trapp M, Chen NC, Schwander K, Moss S, Palkimas S.   +7 more
europepmc   +1 more source

Implications of relying on manufacturer patient support programs for access to high-cost specialty and biologic medicines: a critical qualitative study. [PDF]

BMJ Open
Grundy Q, Hart D, Lexchin J, Persaud N, Tadrous M, Gagnon MA.   +5 more
europepmc   +1 more source